Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis

NCT01090063 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Moderate to Severe Palmar Plantar Psoriasis

Interventions

DRUG: Ustekinumab

Sponsor

Tufts Medical Center

Collaborators

[object Object]